Investing NewsPfizer Earnings Weighed Down Again by Dwindling COVID SalesOctober 31, 2023 by admin 0 Comments The company reiterated its recent reduction in full-year sales guidance by $9 billion as it doubled down on efforts to trim costs. Articles You May Like Shhh! 3 Secret Lithium Stocks Flying Below Wall Street’s Radar Optimal Use of Financial Leverage in a Corporate Capital Structure How to Establish a Blind Trust Stock Market Crash Warning: Don’t Get Caught Holding These 3 Blue-Chip Stocks Corporate Espionage: Fact and Fiction